NCT04264156 - A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 18, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

March 28, 2021

Conditions

Respiratory Distress Syndrome, Newborn

Interventions

COMBINATION_PRODUCT

Lucinactant for Inhalation

A drug-device combination product that delivers aerosolized SRT to preterm neonates with RDS who are being supported with nasal continuous positive airway pressure (nCPAP).

OTHER

nCPAP Only

Nasal continuous positive airway pressure (nCPAP) alone

Trial Locations (3)

41-902

Szpital Specjalistyczny nr 2 w Bytomiu Oddzial Noworodkow Blok Va, Bytom

60-535

Ginekologiczno-Polozniczy Szpital Kliniczny Uniwewersytetu Medycznego im. Karola Marcinkowskiego, Poznan

70-780

"Samodzielny Publiczny Spcjalistyczny Zaklad Opieki Zdrowotnej Zdroje, Oddzial Noworodkow", Szczecin